CUSIP: 68234L207
Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,638,326
-
Share change
-
+264,354
-
Total reported value
-
$2,802,342
-
Price per share
-
$1.71
-
Number of holders
-
19
-
Value change
-
+$452,389
-
Number of buys
-
7
-
Number of sells
-
6
Quarterly Holders Quick Answers
What is CUSIP 68234L207?
CUSIP 68234L207 identifies ONCS - ONCOSEC MED INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2016
-
Previous quarter:
Q2 2016
Recent filing periods for CUSIP 68234L207:
Institutional Holders of ONCOSEC MED INC - COM NEW (ONCS) as of Q3 2016
As of 30 Sep 2016,
ONCOSEC MED INC - COM NEW (ONCS) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,638,326 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Fund Advisors, DEUTSCHE BANK AG\, NORTHERN TRUST CORP, Janney Montgomery Scott LLC, BlackRock Institutional Trust Company, N.A., and Bank of New York Mellon Corp.
This page lists
19
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.